【レポートの概要（一部）】
1. Report Overview
1.1 Pharma Contract Sales: World Market Review 2014
1.2 Why You Should Read This Report
1.3 How This Report Delivers
1.4 Main Questions Answered by this Analysis
1.5 Who Is This Study For?
1.6 Methods of Research and Analysis
1.7 Frequently Asked Questions (FAQs)
1.8 Some Associated Reports
1.9 About Visiongain
2. Defining the Pharma Contract Sales Market
2.1 An Introduction to Pharma Contract Sales
2.2 Pharma Sales Models 2014 – Multiple Channels
2.3 Detailing Healthcare Professionals – Is That Still Relevant?
2.4 There Are Benefits to Outsourcing Pharma Sales
2.4.1 What Services Do CSOs Offer?
2.4.2 The Rise in Pharma Contract Sales
2.5 The Need for New Sales Models – Creative Yet Ethical
3. World Pharma Contract Sales Market: Outlook and Forecast 2015-2025
3.1 World Pharma Contract Sales Market 2014
3.1.1 Pharma Contract Sales Market by Sector 2014
3.1.2 Recent Growth in Outsourced Pharma Sales
3.2 World Pharma Contract Sales Market Forecast 2015-2025
3.2.1 Maturing Brands and New Product Launches to Drive Growth to 2025
3.2.2 Increasing Restraints on Healthcare Budgets to Drive Market Access Consultancy
3.2.3 Pharma Contract Sales: Market Restraints 2015-2025
3.3 Leading Therapeutic Areas for Pharma Contract Sales 2015-2025
3.4 Contract Sales for Cardiovascular Drugs 2015-2025
3.4.1 Growth for Cardiovascular Disease Services: Submarket Forecast 2015-2025
3.5 Metabolic Disorders: Pharma Contract Sales 2015-2025
3.5.1 Metabolic Disorder Services: New Obesity and Diabetes Product Launches Drive to Growth 2015-2025
3.6 Contract Sales for Cancer Drugs 2015-2025
3.6.1 Oncology Sales Services: Submarket Forecast 2015-2025
3.7 Chapter Summary: Strong Growth Forecast for the Pharma Contract Sales Market 2015-2025
4. Leading Service Sectors of the Pharma Contract Sales Market 2015-2025
4.1 Detailing Leads the Contract Sales Market 2014
4.1.1 Rising Demand for Inside and Outside Sales Teams
4.2 Personal Promotion: Contract Detailing Submarket 2015-2025
4.2.1 Detailing Services Offered by CSOs
4.2.2 Contract Detailing: Submarket Forecast 2015-2025
4.2.3 CSOs Are Affected by Doctor Access as Much as Internal Reps
4.2.4 Field Sales Flexibility to Drive Submarket Growth 2015-2025
4.3 Contract Non-Personal Promotion Submarket 2015-2025
4.3.1 Contract Non-Personal Promotion: Submarket Forecast 2015-2025
4.3.1.1 Submarket Drivers and Restraints 2015-2025: Multichannel Marketing
4.3.2 Contract Teledetailing Submarket 2015-2025
4.3.2.1 Submarket Forecast 2015-2025: Rapid Growth in Demand for Contact Centres
4.3.2.2 Contract Teledetailing: Submarket Drivers and Restraints 2015-2025
4.3.3 Contract eDetailing Submarket 2015-2025
4.3.3.1 The Contract Edetailing Submarket Will Grow Fastest 2015-2025
4.3.3.2 Contract Edetailing: Submarket Drivers and Restraints 2015-2025
4.4 Medical Education Services Submarket 2015-2025
4.4.1 Medical Education Services Submarket: Revenue Forecast 2015-2025
4.4.2 Complex Drug Development to Drive Submarket Growth to 2025
4.5 Sample Management Services Submarket 2015-2025
4.5.1 Steady Growth for Sample Management Services to 2025
4.5.2 Sample Management Services: Submarket Drivers and Restraints 2015-2025
4.5.3 J. Knipper & Co.: A US Leader in Sample Management Services
4.5.3.1 J. Knipper Acquires Sample Management Divisions from Leading CSOs 2010-2014
4.5.3.2 New Technologies to Drive Growth 2015-2025
4.6 Chapter Summary: Continued High Demand for Contract Detailing Services
5. Leading National Submarkets for Pharma Contract Sales: Regulatory and Commercial Outlook 2015-2025
5.1 Leading National Submarkets for Pharma Contract Sales 2014
5.2 Leading National Pharma Contract Sales Submarkets: Outlook and Forecast 2015-2025
5.2.1 How Will Market Shares for Leading Countries Change to 2025?
5.3 Pharma Sales Regulatory Developments
5.3.1 Physician Payment Legislation in the US, Europe and Japan 2011-2014
5.3.1.1 The Physician Payment Sunshine Act (PPSA)
5.3.1.2 Physician Payments in France: Increased Scrutiny from 2013
5.3.2 Domestic and International Concerns over Bribery: Recent Legislation in the US and UK
5.3.2.1 Promotional Products in the EU: New Rules 2013
5.3.3 New Market Access Requirements in EU5 Countries 2011-2014
5.3.3.1 AMNOG: Stricter Pricing for Drugs in Germany
5.3.3.2 Healthcare Reform in France: Pricing and Reimbursement Set for Change?
5.3.3.3 Pricing Models and Clinical Commissioning Groups in the UK
5.3.4 Overtime for Sales Reps in the US: Rule Clarifications 2012-2014
5.4 The US Pharma Contract Sales Submarket 2015-2025
5.4.1 Pharma Sales Regulation in the US
5.4.2 US Submarket: Revenue Forecast 2015-2025
5.5 Pharma Contract Sales in the EU 2015-2025
5.5.1 Regulating Pharma Sales in the EU
5.5.2 Commercial Outlook for Pharma Contract Sales in the EU: Submarket Forecast 2015-2025
5.5.3 UK Submarket: Revenue Forecast 2015-2025
5.5.4 Strong Growth for the German Submarket to 2025
5.5.5 French Pharma Contract Sales Submarket: Revenue Forecast 2015-2025
5.5.6 Italian Submarket Forecast 2015-2025: Price Restrictions to Restrain Growth
5.5.7 Spanish Pharma Contract Sales Submarket: Revenue Forecast 2015-2025
5.6 Japanese Pharma Contract Sales: Regulatory and Commercial Outlook 2015-2025
5.6.1 Pharma Contract Sales in Japan 2013-2014
5.6.2 Rise in Outsourcing Rate to Drive Japanese Submarket Growth 2015-2025
5.7 Chapter Summary: Strong Growth for Leading National Submarkets 2015-2025
6. Emerging National Submarkets for Pharma Contract Sales: Regulatory and Commercial Outlook 2015-2025
6.1 Pharma Contract Sales in Emerging National Submarkets 2014
6.2 Outlook for Emerging National Submarkets: Revenue Forecasts 2015-2025
6.3 Improving Regulation for Pharma Sales in Emerging Markets
6.4 Pharma Contract Sales in China 2015-2025
6.4.1 Rising In-House and Outsourced Sales Rep Numbers 2011-2013
6.4.2 Concerns over Bribery in Chinese Pharma Sales
6.4.3 Chinese Pharma Contract Sales Submarket: Revenue Forecast 2015-2025
6.5 India: Pharma Contract Sales Submarket 2015-2025
6.5.1 New Pharma Sales Rules Proposed for 2015
6.5.2 Demand for Field Sales Teams to Drive Growth in the Indian Submarket Growth to 2025
6.6 Pharma Contract Sales in Brazil 2015-2025
6.6.1 State Payment Rules for Drugs in Brazil
6.6.2 Updated Online Marketing Rules for Prescription Drugs
6.6.3 Brazilian Pharma Contract Sales Submarket: Revenue Forecast 2015-2025
6.7 Pharma Contract Sales in Russia 2015-2025
6.7.1 New State Procurement Rules for Drugs 2013
6.7.2 Restricted Interactions between Doctors and Sales Reps in Russia
6.7.3 Russian Pharma Contract Sales Submarket: Revenue Forecast 2015-2025
6.8 Chapter Summary: Outlook for Pharma Contract Sales in Emerging National Markets 2015-2025
7. Pharma Contract Sales: Industry and Market Trends 2015-2025
7.1 Pharma Contract Sales Market: Strengths and Weaknesses 2015
7.2 Pharma Contract Sales Market: Opportunities and Threats 2015-2025
7.3 Pharma Contract Sales Market: STEP Analysis 2015-2025
7.3.1 Social Factors Affecting Pharma Sales to 2025
7.3.1.1 The Role of Ethics in Pharma Sales
7.3.2 Technological Developments to Improve Sales Strategies
7.3.2.1 Smartphones and Tablets for New Detailing Strategies
7.3.2.2 Closed Loop Marketing (CLM)
7.3.2.3 Cloud Computing and its Use Pharma Contract Sales
7.3.2.4 Customer Relationship Management (CRM)
7.3.2.5 Can Big Data Play a Role in Pharma Sales?
7.3.2.6 How Will Pharma Use Social Media in Sales?
7.3.3 Economic Pressures Are Limiting Healthcare and Marketing Budgets
7.3.4 Political Issues: Stricter Regulations for Pharma Sales in Markets Worldwide
7.4 Trends in Outsourced Pharma Sales 2015-2025
7.4.1 Cuts to In-House Sales Staff Will Continue from 2015
7.4.2 Strategic Partnering to Provide Long-Term Revenue Growth
7.4.3 Leading CSOs Will Consolidate to Increase Market Penetration
7.4.4 There Are Risks in Outsourcing Pharma Sales
7.5 Drug Development Trends Affecting Pharma Sales 2015-2025
7.5.1 How Will Orphan Drug Development Influence Pharma Sales?
7.5.2 Promotion for Biosimilars Drugs 2015-2025
7.5.3 There Will be Greater Demand for Specialty Medicine
7.5.4 The Appeal of Emerging National Markets
7.6 New Sales Models Are Needed
7.6.1 Sales Reps Are Struggling for Access to Healthcare Professionals
7.6.2 Multichannel Marketing to Overcome Problems of Access
7.6.3 Key Account Management (KAM)
7.6.4 Silos in Sales and Marketing
7.6.5 The Use of Key Opinion Leaders (KOLs) in Pharma Sales
7.7 Market Access and Contract Medicine Sales
7.7.1 There Are Emerging Stakeholders in Pharma Sales
7.7.2 Changes in Market Access in the US 2015-2025: The Rise of ACOs
7.7.3 Market Access in the EU 2015-2025
7.7.4 The Role of CSOs in Improved Market Access
7.8 Chapter Summary: Main Trends Shaping Pharma Contract Sales 2015-2025
8. Leading Contract Sales Organisations (CSOs), 2015
8.1 Few CSOs Compete on a Global Scale
8.2 Quintiles: World Market Leader for Contract Sales and Market Access
8.2.1 New Services and Strategic Partnerships
8.2.2 Quintiles Integrated Healthcare Services: Performance 2010-2014
8.2.3 Outlook for Quintiles’ Contract Sales 2015-2025
8.3 inVentiv Health
8.3.1 inVentiv is Expanding in Asia
8.3.2 inVentiv’s Commercial Services: Recent Financial Performance
8.3.3 inVentiv Health: Contract Sales Outlook 2015-2025
8.4 UDG Healthcare
8.4.1 Geographic and Service Growth through Acquisitions
8.4.2 UDG Healthcare: Financial Performance 2010-2014
8.4.3 A Leader in Europe 2015-2025?
8.5 North America: Leading Regional-Level CSOs
8.5.1 PDI
8.5.1.1 Broad Service Portfolio
8.5.1.2 New Sales Models for Medical Devices
8.5.1.3 Financial Performance 2010-2014
8.5.1.4 PDI: Contract Sales Outlook 2015-2025
8.5.2 Publicis Touchpoint Solutions
8.5.2.1 New Services in Recent Years
8.5.3 OnCall
8.5.3.1 OnCall Partners with Promius Pharma
8.6 Leading Domestic CSOs in Europe
8.6.1 Marvecs: A Local Leader in Germany
8.6.1.1 New Services Added: Sales 3.0
8.6.2 Sofip: Contract Sales for the French Submarket
8.7 CSOs in the Asia Pacific Region
8.7.1 Global Leaders Dominate in Japan
8.7.2 CMIC Accounts for 10% of Outsourced Sales Reps in Japan
8.7.2.1 CMIC CSO: Financial Performance 2010-2014
8.7.3 Leading Players in China Are Not Just CSOs
8.8 Chapter Summary: Growth Strategies for Market Leaders
9. Interviews from Visiongain’s Industry Survey
9.1 Walter R. Dewees, Executive Vice-President, OnCall LLC
9.1.1 OnCall, LLC
9.1.2 Promotional Outsourcing in the US
9.1.3 Increasing Engagement via Technology-Enabled Multi-Channels
9.1.4 Growing Medical Science Liaison Function
9.1.5 Risk-Sharing Agreement
9.2 Tony Swift, Managing Director, Apodi, UK
9.2.1 Apodi
9.2.2 Market Access Challenges in the UK
9.2.3 CSOs Can Promote Partnership Between Pharma and the NHS
9.2.4 Value Propositions Offered by CSOs
9.3 Holger C.W. Fürstenberg, CEO, Hilver, the Netherlands
9.3.1 Hilver
9.3.2 Integrating CLM and Digital Strategy Remains a Challenge
9.3.3 CLM Implementation – Bridging Sales and Marketing
9.3.4 Company Culture is yet to Fully Embrace Digital Toolsets
9.3.5 Digital Tools Facilitate Unparalleled Customer Service
10. Conclusions of the Research and Analysis
10.1 The World Pharma Contract Sales Market in 2014
10.1.1 Contract Detailing Services Dominate CSO Revenues in 2014
10.1.2 Spending on Contract Sales is Highest in the US and EU
10.2 Outlook for the Pharma Contract Sales Market 2015-2025
10.2.1 Growth Trends for Leading Submarkets 2015-2025
10.2.1.1 Therapeutic Sector Growth 2015-2025
10.2.2 Commercial Drivers for Pharma Contract Sales from 2015
【レポート販売概要】
■ タイトル：医薬品販売業務受託機関（CSO）の世界市場■ 英文：Pharma Contract Sales Industry and Market: Trends and Forecasts 2015-2025
■ 発行日：2015年3月
■ 調査会社：visiongain
■ 商品コード：VGAIN503176
■ 調査対象地域：グローバル
- 心電図装置（医療機器）のグローバル新興国市場（2012-2018）BRICSS Electrocardiogram (ECG) Devices market value is expected to reach US$64 million by 2016, primarily supported by the product types - Resting ECG and Stress ECG. China accounts for nearly 24% of the market share and India claims more than 24%. In terms of CAGR, India is the fastest growing region while China and Russia are just behind. Among the product types, Resting ECG accounts more nearly …
- 世界の軍事航空MRO（保守、修理、点検）市場（2014-2024）Summary The Global Military Aviation MRO Market 2014-2024 Report published by Strategic Defence Intelligence, provides readers with a detailed analysis of both historic and forecast global industry values, factors influencing demand, the challenges faced by industry participants, analysis of industry leading companies, and key news. Key Findings - The global military aviation MRO market is expecte …
- 硝酸ナトリウムの世界市場2016-2020About Sodium Nitrate Sodium nitrate is a crystalline salt used to make fertilizers and gunpowder. It is found in the Earth’s crust in mineral deposits called caliche ore. Chile and Peru are the global leaders in the production of sodium nitrate; that is why it is also known as Chile or Peru saltpeter. Sodium nitrate is a strong oxidizer. It is an essential plant nutrient and helps improve the nutr …
- SM Energy Company：石油・ガスの開発・生産動向及びコスト分析- Q3, 2013SM Energy Company Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary SM Energy Company Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key …
- 末梢血管装置（医療機器）のグローバル新興国市場（2012-2018）BRICSS Peripheral Vascular Devices sector forecasts to reach at US$732 million by 2016. China accounts for highest percentage approximately 34% (2015) and India follows next with nearly 25% (2018) of the market share. BRICSS projections for Peripheral Vascular Stents market share indicate nearly 36% by 2015 leaving the rest of the market to the Vascular Closure Devices, AAA Stent Grafts, Inferior …
- 骨髄異形成症候群（MDS）治療薬の世界市場2015-2019About Myelodysplastic Syndrome Myelodysplastic syndrome is a group of hematologic disorders that arise in the bone marrow and spread into the blood. The syndrome is characterized by the inability of the hematopoietic cells produced in the bone marrow to attain maturity. Cytological dysplasia is a common feature of the syndrome, progressing to acute myeloid leukemia in about 30% of individuals with …
- マイクロセグメンテーションの世界市場：コンポーネント別（ソフトウェア、サービス）、サービス別（マネージド、プロフェッショナル）、セキュリティタイプ別（ネットワーク、データベース、アプリケーション）、導入タイプ別、組織別、地域別予測Global Microsegmentation Market to reach USD 3752 million by 2025. Global Microsegmentation Market valued approximately USD 650 million in 2017 is anticipated to grow with a healthy growth rate of more than 24.50% over the forecast period 2017-2025. Technological advancements, increasing ransomware attacks on connected devices, and growing usage of security virtualization and cloud computing are s …
- 世界のセキュリティーSaaS市場動向（2012-2016）TechNavio's analysts forecast the Global Security Software as a Service (SaaS) market to grow at a CAGR of 13.7percent over the period 2012-2016. One of the key factors contributing to this market growth is the ability of security SaaS solutions to reduce the total cost of ownership for key end-users of the market. The Global Security SaaS market has also been witnessing increased R&D spending by …
- シェアードサービスの世界市場2016-2020About the Shared Services Market The concept of shared services was designed to manage single or multiple functions of business units by sharing information and resources. SSCs manage the functions of business units of organizations. SSCs can be set up anywhere on the globe depending on the business requirements of clients. However, the location of SSCs is a strategic decision taken by an organiza …
- BYOD及び企業におけるウェアラブル技術The line between consumer and business technology has gotten increasingly blurry during the past decade. Consumer devices are almost indistinguishable from enterprise gear. But the gap between software and applications in each category is far wider. However, wearable computing is distinct from the first iteration of BYOD. The enterprise sector will lead this time, and consumers may or may not foll …
- 世界のApplication Delivery Network (ADN) 市場Globally, companies are increasingly deploying web-based collaboration applications such as Microsoft Outlook and SharePoint, Enterprise Resource Planning (ERP) applications such as SAP and Oracle, and static content sharing to leverage the machine-to-machine interactions between distributed enterprises. This makes networking a very crucial part of various businesses. Companies are facing conflict …
- アジアの空港/海港および産業用タイヤ市場2016-2020About Port and Industrial Tire Market in Asia Pacific Port and industrial tires are designed for use in port handling equipment and airport ground handling equipment. These tires fall under the tire market segment called off-the-road (OTR) tires. The OTR tires can be segmented based on end-users, or the industries that use them, which include mining, construction, seaports, and airports among othe …
- 線材加工機の世界市場ABSTRACTAbout Wire Processing Machines The global market for wires and cables has witnessed a significant growth rate over the past few years, which in turn has influenced the wire processing machines market globally. The demand for these wires and cables is majorly driven by automotive and aerospace industries. These industries use an assembly of wires that transmits electrical signals; in additi …
- 赤痢菌検査の世界市場2015The report presents a detailed analysis of the Shigella diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Shigella definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments: - Hospitals …
- ヘパリン検査市場：米国、ヨーロッパ、日本The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next ten years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation. Coagulation testing in general, and Heparin testing specifically, will become more standardized, offering opp …
